| Patents for A61P 3 - Drugs for disorders of the metabolism (129,789) |
|---|
| 04/05/2007 | WO2007038045A1 Tetrahydro-indazolyl cannabinoid modulators |
| 04/05/2007 | WO2007038036A1 Hexahydro-cycloheptapyrazole cannabinoid modulators |
| 04/05/2007 | WO2007037554A1 Adsorbent for advanced glycation endproducts |
| 04/05/2007 | WO2007037534A1 2-heteroaryl-substituted indole derivative |
| 04/05/2007 | WO2007037513A1 Aryl-substituted nitrogen-containing heterocyclic compound |
| 04/05/2007 | WO2007037438A1 Ameliorating agent for metabolic syndrome |
| 04/05/2007 | WO2007037425A1 Anti-diabetic composition |
| 04/05/2007 | WO2007037423A1 Antidiabetic agent |
| 04/05/2007 | WO2007037413A1 Agent for promoting glucagon-like peptide 1 secretion, food or drink for promoting glucagon-like peptide 1 secretion, agent for inhibiting postprandial increase in blood sugar level and food or drink for inhibiting postprandial increase in blood sugar level |
| 04/05/2007 | WO2007037297A1 Composition effective for prevention and treatment of adult disease |
| 04/05/2007 | WO2007037296A1 Medical agent containing insulin resistance improving agent |
| 04/05/2007 | WO2007037249A1 Cellooligosaccharide-containing composition |
| 04/05/2007 | WO2007037010A1 Phenoxyacetic acid derivatives and drugs using the same |
| 04/05/2007 | WO2007036730A1 Thiophene derivatives as ppar agonists i |
| 04/05/2007 | WO2007036727A1 Condensed pyrazole derivatives as ppar agonists ii |
| 04/05/2007 | WO2007036044A1 Combination of polychitosamine and fibrate for the prevention and treatment of hyperlipidemia |
| 04/05/2007 | WO2007036041A1 Sialidase inhibitors for the treatment of cardiovascular disease |
| 04/05/2007 | WO2007036016A1 Therapeutic molecules and their uses |
| 04/05/2007 | WO2007015003A3 Novel crystalline iii form of agomelatine, method of the preparation thereof and pharmaceutical compositions containing said form |
| 04/05/2007 | WO2007009724A3 Cycloalkane-substituted pyrazoline derivatives, their preparation and use as medicaments |
| 04/05/2007 | WO2007009723A3 Azepane- or azocane-substituted pyrazoline derivatives, their preparation and use as medicaments |
| 04/05/2007 | WO2007009700A3 Use of substituted pyrazoline compounds for the treatment of the lipid parameters of the metabolic syndrome |
| 04/05/2007 | WO2007008111A3 Method of loosing weight |
| 04/05/2007 | WO2007007982A3 Glucose uptake modulator and method for treating diabetes or diabetic complications |
| 04/05/2007 | WO2007007982A2 Glucose uptake modulator and method for treating diabetes or diabetic complications |
| 04/05/2007 | WO2006138163A3 Anti-hypercholesterolemic compounds |
| 04/05/2007 | WO2006110491A3 Complementary compositions to reduce blood glucose levels and treat diabetes |
| 04/05/2007 | WO2006086447A3 Pyridazine derivatives and their use as therapeutic agents |
| 04/05/2007 | WO2003070751A3 Partial peptide mimetics and methods |
| 04/05/2007 | US20070078179 Use of a fibrate and orlistat for the treatment of obesity |
| 04/05/2007 | US20070078168 Pyridine carboxylic acid derivatives as glucokinase modulators |
| 04/05/2007 | US20070078153 4-Oxoimidazolidine-2-spiropiperidine derivatives |
| 04/05/2007 | US20070078115 Phytosterol and/or phytostanol derivatives |
| 04/05/2007 | US20070077597 Method for identifying modulators of G protein coupled receptor signaling |
| 04/05/2007 | DE60210604T2 Polymer-kontrolliertes induziertes viskoses ballaststoffsystem und dessen verwendungen Polymer controlled induced viscous fiber system and uses its |
| 04/05/2007 | DE102005046892A1 Composition, useful for the treatment of e.g. oliguria, comprises plant extracts of Alismatis Orientale, Plantago asiatica or Plantago depressa and Polygonum multiflorum |
| 04/05/2007 | CA2624686A1 Therapeutic molecules and their uses |
| 04/05/2007 | CA2624183A1 Thiophene derivatives as ppar agonists i |
| 04/05/2007 | CA2624176A1 Condensed pyrazole derivatives as ppar agonists ii |
| 04/05/2007 | CA2624162A1 Aryl-substituted nitrogen-containing heterocyclic compound |
| 04/05/2007 | CA2623958A1 2-heteroaryl-substituted indole derivative |
| 04/05/2007 | CA2623745A1 Hexahydro-cycloheptapyrazole cannabinoid modulators |
| 04/05/2007 | CA2623525A1 Tetrahydro-indazolyl cannabinoid modulators |
| 04/05/2007 | CA2623475A1 Combination of polychitosamine and fibrate for the prevention and treatment of hyperlipidemia |
| 04/05/2007 | CA2621255A1 Amido compounds and their use as pharmaceuticals |
| 04/04/2007 | EP1770162A1 Immunological compositions to modulate myostatin in vertebrate subjects |
| 04/04/2007 | EP1770159A1 Process for manufacturing a pharmaceutical composition for treating diabetes |
| 04/04/2007 | EP1770083A1 Inorganic ion receptor-active compounds |
| 04/04/2007 | EP1769800A2 Estrogen replacement therapy |
| 04/04/2007 | EP1769793A1 Therapeutic or preventive drug for diabetes, obesity, or arteriosclerosis |
| 04/04/2007 | EP1768968A1 2-((hetero) aryl)-benzoxazole compounds and derivatives, compositions and methods for stabilizing transthyretin and inhibiting transthyretin misfolding |
| 04/04/2007 | EP1768701A2 Carrier for medicaments for obtaining oral bioavailability |
| 04/04/2007 | EP1768691A2 Aequorin-containing compositions and methods of using same |
| 04/04/2007 | EP1768675A1 Combination therapies employing nicotinic acid derivatives or fibric acid derivatives |
| 04/04/2007 | EP1768664A1 Combination of dpp-iv inhibitors and compounds modulating 5-ht3 and/or 5-ht4 receptors |
| 04/04/2007 | EP1536797B1 1-amido-4-phenyl-4-benzyloxymethyl-piperidine derivatives and related comounds as neurokinin-1 (nk-1) antagonsists for the treatment of emesis, depression, anxiety and cough |
| 04/04/2007 | EP1532135B1 Nf-kb inhibitors |
| 04/04/2007 | EP1414858B1 Single chain camelid vhh antibodies, method for their production in a mammal, and their uses |
| 04/04/2007 | EP1383501B1 Acylated piperidine derivatives as melanocortin-4 receptor agonists |
| 04/04/2007 | EP1331932B1 Use of xestospongin c for treating or preventing hiv infection |
| 04/04/2007 | EP1259595B1 Integrin antagonists |
| 04/04/2007 | EP0969835B1 Use of central cannabinoid receptor antagonists for regulating appetency |
| 04/04/2007 | CN2885254Y A calcium iron powder capsule |
| 04/04/2007 | CN1942469A Condensed pyridine derivatives useful as A28 adenosine receptor antagonists |
| 04/04/2007 | CN1942198A Anorectic agent and air regulator for diet |
| 04/04/2007 | CN1942184A Niosame having metal porphyrin complex embedded therein, process for it and drug with use thereof |
| 04/04/2007 | CN1942182A Inhibitors of dipeptidylpeptidase IV for regulating glucose metabolism |
| 04/04/2007 | CN1942181A Tablet containing branched chain amino acid and process for producing the same |
| 04/04/2007 | CN1939895A Compound, composition and method for preventing from neurodegeneration in injury of central nervous system |
| 04/04/2007 | CN1939540A Medicine composition containing insulin sensibilizer and B-family vatamines |
| 04/04/2007 | CN1939538A Use of osteopontin for the treatment and/or prevention of neurologic diseases |
| 04/04/2007 | CN1939532A Use of fungal immunomodulatory protein |
| 04/04/2007 | CN1939529A Compositions and methods for modulating connexin hemichannels |
| 04/04/2007 | CN1939509A Fructus rubi and gordon euryale seed capsules and preparation thereof |
| 04/04/2007 | CN1939508A Hos sophorae and radix puerariae capsules and production thereof |
| 04/04/2007 | CN1939506A Vision-improving preparation with depressor, blood-sugar and blood-fat lowering functions and its making method |
| 04/04/2007 | CN1939481A Blood fat lowering powder with wild Chinese medicinal herbs |
| 04/04/2007 | CN1939475A Fructus lycii kudzuvine root capsule sand production thereof |
| 04/04/2007 | CN1939472A Quality control of compound preparation for treating diabetes |
| 04/04/2007 | CN1939452A Yixin ketone dispersing tablets |
| 04/04/2007 | CN1939447A Yixinkang table and its preparation |
| 04/04/2007 | CN1939445A Preparation and use for loquat-leaf extract |
| 04/04/2007 | CN1939435A Hypolipidemic composition and its use |
| 04/04/2007 | CN1939418A Chinese medicinal herb composition with food and medicine consangunity |
| 04/04/2007 | CN1939351A Method for inspecting lucid ganoderma product quality |
| 04/04/2007 | CN1939333A Preparation of injecting soluble vitamines |
| 04/04/2007 | CN1939332A Medical usage of S-adenyhomotype cysteine |
| 04/04/2007 | CN1939329A Metabolic improver and its usage in diet tablet, health-care products and food |
| 04/04/2007 | CN1939324A Medical usage of periplocin A and E |
| 04/04/2007 | CN1939310A Composition for losing weight |
| 04/04/2007 | CN1939309A Alprostadil preparation and its making method |
| 04/04/2007 | CN1939303A Novel composition and use. |
| 04/04/2007 | CN1939301A Slow-releasing preparation containing Vitamin E niacin ester and its making method |
| 04/04/2007 | CN1939296A Theapolyphenol composition and its preparation |
| 04/04/2007 | CN1308438C Compositions including ammonia oxidizing bacteria and methods of using same |
| 04/04/2007 | CN1308431C Buck-wheat flavone vinega soft capsule and preparing method |
| 04/04/2007 | CN1308349C Food product with prolonged energy release |
| 04/04/2007 | CN1308320C Substituted naphthyl benzofuran derivatives as inhibitors of plasminogen activator inhibitor-1 (PAI-1) |
| 04/04/2007 | CN1308311C Novel pyridine- and quinoline-derivatives |
| 04/04/2007 | CN1308310C Nitrogenous aromatic ring compounds |